NEW CHOLESTEROL GUIDELINES: EARLIER TESTING RECOMMENDED
Imagine stopping heart disease before it ever has a chance to start. That’s the goal behind a sweeping new U.S. cholesterol guideline: catch problems earlier, make prevention more personal, and give people a real shot at lifelong heart health.
Announced March 28, 2026, at the American College of Cardiology’s 75th annual meeting, these updated rules—crafted by the American College of Cardiology and the American Heart Association—are the first major overhaul since 2018. They’re all about shifting the focus: don’t just wait for trouble, get ahead of it.
What’s New? Start Sooner, Get Personal
Forget waiting until middle age to worry about cholesterol. The new advice? Start screening much younger—sometimes even in childhood, especially if heart disease runs in your family. Doctors are being told to look beyond just LDL (“bad”) cholesterol and check genetic risk factors like lipoprotein(a), which you can inherit and which can silently raise your odds of a heart attack.
The guidelines also debut a new risk calculator—PREVENT—that crunches not just the usual numbers (age, blood pressure, cholesterol) but also things like blood sugar and kidney function, using a massive dataset from over 6 million people. The goal: a much sharper picture of your heart risk not just over the next 10 years, but for decades to come.
Why Earlier Screening Matters
You might not realize it, but about one in four U.S. adults has high LDL cholesterol—a key player in the slow build-up of plaque inside arteries. That process, called atherosclerosis, can quietly clog blood vessels for years before striking with a heart attack or stroke. Catching risky cholesterol levels early, especially if you have a family history or certain conditions, means you can start making changes long before the damage is done.
The basics haven’t changed: eat well, stay active, don’t smoke, sleep enough, and keep your weight in check. According to Dr. Roger Blumenthal of Johns Hopkins, who helped write the new rules, 80–90% of heart disease is tied to things we can actually do something about.
Personalized Risk: More Than Just Numbers
The guidelines ask doctors to think bigger: family history, conditions like rheumatoid arthritis, early menopause, or pregnancy complications can all dial up your risk. For kids with an inherited cholesterol disorder (familial hypercholesterolemia), screening should start as young as age 9—or even earlier.
And there’s a push for everyone to get a one-time test for lipoprotein(a), or Lp(a). If your level is high, your risk for heart disease can jump 40% or even double.
A New Way to Predict the Future: The PREVENT Calculator
The old risk calculators only told you about your next 10 years. PREVENT, the new kid on the block, helps you and your doctor see 30 years ahead, starting at age 30. It’s built on far more data than before, and factors in kidney health and blood sugar, painting a fuller picture of your lifelong risk.
Fine-Tuning the Approach: Extra Tests and Tailored Treatments
If your risk is borderline, doctors now have more tools to figure out what to do. Tests for inflammation, more detailed cholesterol markers, and scans for calcium in your arteries all help clarify your situation. For some, these advanced tests could mean more aggressive treatment; for others, it could spare unnecessary medication.
Imaging—like a coronary artery calcium scan—can spot early plaque build-up, helping target the right treatments to the right people.
More Treatment Options, Lower Targets
The guidelines spell out new treatment strategies for just about everyone: young, old, people with diabetes or kidney disease, even those pregnant or breastfeeding. Statins remain the workhorse, but newer drugs like ezetimibe, bempedoic acid, and injectable PCSK9 inhibitors are in the mix for people who need extra help lowering cholesterol.
The numbers have gotten stricter, too. If you don’t have heart disease, aim for LDL under 100 mg/dL. Intermediate risk? Go for under 70. High risk? Under 55 is the goal. There are also new targets for other cholesterol markers, like non-HDL cholesterol and apolipoprotein B.
What’s Next? Even Lower Targets on the Horizon
An editorial alongside the new guidelines hints that the future might mean even lower cholesterol targets for people with moderate atherosclerosis, especially after a major trial (VESALIUS-CV) found big benefits from aggressive cholesterol-lowering combinations.
This 2026 update is the result of years of collaboration among top heart specialists and medical groups, all aiming to keep people healthier, longer—starting much earlier than before.
The bottom line: When it comes to cholesterol, sooner is better, and one-size-fits-all advice is out. Your heart’s future depends on what you do now.

Comments
Post a Comment